Corrigendum re: `Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens` [Eur Urol 2018;73:462-8] (European Urology)
A review of potential conflicts of interest for all the authors in relation to this study revealed further items that Rafael Morales-Barrera and Enrique Grande wish to disclose. The conflicts of interest statement with full disclosures is therefore as follows.
